530 related articles for article (PubMed ID: 18512489)
1. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
[TBL] [Abstract][Full Text] [Related]
2. Expression of bone-regulatory proteins in human valve allografts.
Shetty R; Pepin A; Charest A; Perron J; Doyle D; Voisine P; Dagenais F; Pibarot P; Mathieu P
Heart; 2006 Sep; 92(9):1303-8. PubMed ID: 16449517
[TBL] [Abstract][Full Text] [Related]
3. RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.
Panizo S; Cardus A; Encinas M; Parisi E; Valcheva P; López-Ongil S; Coll B; Fernandez E; Valdivielso JM
Circ Res; 2009 May; 104(9):1041-8. PubMed ID: 19325147
[TBL] [Abstract][Full Text] [Related]
4. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
Kiechl S; Werner P; Knoflach M; Furtner M; Willeit J; Schett G
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):801-11. PubMed ID: 17173497
[TBL] [Abstract][Full Text] [Related]
5. OPG, RANK and RANK ligand expression in thyroid lesions.
Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
[TBL] [Abstract][Full Text] [Related]
6. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
7. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.
D'Amelio P; Isaia G; Isaia GC
J Endocrinol Invest; 2009; 32(4 Suppl):6-9. PubMed ID: 19724159
[TBL] [Abstract][Full Text] [Related]
8. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
[TBL] [Abstract][Full Text] [Related]
10. Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling.
Pivonka P; Zimak J; Smith DW; Gardiner BS; Dunstan CR; Sims NA; Martin TJ; Mundy GR
J Theor Biol; 2010 Jan; 262(2):306-16. PubMed ID: 19782692
[TBL] [Abstract][Full Text] [Related]
11. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
12. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
Kaden JJ; Dempfle CE; Kiliç R; Sarikoç A; Hagl S; Lang S; Brueckmann M; Borggrefe M
Exp Mol Pathol; 2005 Feb; 78(1):36-40. PubMed ID: 15596058
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
[TBL] [Abstract][Full Text] [Related]
14. Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves.
Lis GJ; Czubek U; Jasek-Gajda E; Łoboda A; Dulak J; Nessler J; Kapelak B; Sadowski J; Litwin JA
Pol Arch Med Wewn; 2016; 126(3):149-58. PubMed ID: 27003233
[TBL] [Abstract][Full Text] [Related]
15. Cells of primarily extra-valvular origin in degenerative aortic valves and bioprostheses.
Skowasch D; Schrempf S; Wernert N; Steinmetz M; Jabs A; Tuleta I; Welsch U; Preusse CJ; Likungu JA; Welz A; Lüderitz B; Bauriedel G
Eur Heart J; 2005 Dec; 26(23):2576-80. PubMed ID: 16115807
[TBL] [Abstract][Full Text] [Related]
16. The imbalance between proliferation and apoptosis contributes to degeneration of aortic valves and bioprostheses.
Tuleta I; Al Ghaddioui AK; Bauriedel G; Wernert N; Preusse CJ; Welz A; Nickenig G; Skowasch D
Cardiol J; 2013; 20(3):268-76. PubMed ID: 23788301
[TBL] [Abstract][Full Text] [Related]
17. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
Kaden JJ; Bickelhaupt S; Grobholz R; Haase KK; Sarikoç A; Kiliç R; Brueckmann M; Lang S; Zahn I; Vahl C; Hagl S; Dempfle CE; Borggrefe M
J Mol Cell Cardiol; 2004 Jan; 36(1):57-66. PubMed ID: 14734048
[TBL] [Abstract][Full Text] [Related]
19. [Expression of osteoprotegerin and soluble ligand of receptor of kappa-B transcription factor activator in the calcification of aortic valve].
Voronkina IV; Irtyuga OB; Smagina LV; Adamova PE; Zhiduleva EV; Malashicheva AB; Sibagatullina YS; Kruk LP; Gordeev ML; Moiseeva OM
Biomed Khim; 2019 Jan; 65(1):57-62. PubMed ID: 30816098
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.
Lommi JI; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Kupari M; Helske S
Atherosclerosis; 2011 Dec; 219(2):538-44. PubMed ID: 21917259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
